Access brought to you by: LOCKSS

Liver Conditions

Prednisolone but Not PTX Improves 28-Day Mortality in Patients with Alcoholic Hepatitis
Current and Soon-to-Be-Approved Regimens Offer High Cure Rates for HCV
DCV/ASV/BCV Improves Sustained Viral Response in Patients with Chronic HCV GT-1 Infection and Compensated Cirrhosis: UNITY-2 Results
Use of Molecular Biology for Identifying Benign Hepatocellular Tumors Leads to More Personalized Medicine
Combination DCV/SOF is Effective in Achieving Sustained Response in Patients with HCV GT-3
Rapid Sustained HCV Viral Load Reductions Achieved with ACH-3102 Plus SOF
SOF Plus GS-5816 Effective in Noncirrhotic Patients Infected with HCV GT-3: ELECTRON-2 Final Results
Advances in the Treatment of Hepatitis C
Sebelipase Alfa Normalizes ALT and Multiple other Disease-Related Abnormalities in Patients with LAL-D
SOF Plus GS-5816 Effective in Noncirrhotic, Treatment-Naïve Patients Infected with HCV Genotypes 1 to 6

Pages